Monocytic Leukemia
Showing 1 - 4 of 4
Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)
Not yet recruiting
- Breast Cancer
- +9 more
- Assessment tool IA3-CP with SDoH
- Assessment tool IA3-CP without SDoH
- (no location specified)
May 22, 2023
Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)
Recruiting
- Leukemia
- +2 more
- Enasidenib mesylat dose escalation
-
Palo Alto, CaliforniaStanford Cancer Institute
May 12, 2022
Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)
Active, not recruiting
- Hodgkin Lymphoma
- +6 more
- Intravenous (IV) and oral Vitamin C
-
Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022
Acute Myeloid Leukemia, Myeloid Leukemia, Monocytic Leukemia Trial in Minneapolis (Daratumumab/rHuPH20, FT538, Fludarabine)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Daratumumab/rHuPH20
- +3 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 3, 2021